Fluoxetine disrupts cholesterol metabolism in endothelial cells via SREBP2 activation.

Authors: Oliveira F, Papa C, Hagemann T, Schipper R, Geier F, Röxe T, Zulfqar F, Prönnecke C, Schmidt L, Stryhanyuk H, Hoffmann A, Kyselova A, Karantanou C, Buckley Y, Farhan MA, Rodríguez-Aguilera JR, Ambreen S, Yao H, Arif A, Martin HNG, Ebert T, Klöting N, Blüher M, Shahzad K, Boeckel JN, Hagberg CE, Chakaroun R, Bibli SI, Sheikh BN

Journal: Translational psychiatry